Marc K. Hellerstein

29.2k total citations · 6 hit papers
297 papers, 19.1k citations indexed

About

Marc K. Hellerstein is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Marc K. Hellerstein has authored 297 papers receiving a total of 19.1k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Physiology, 80 papers in Molecular Biology and 73 papers in Epidemiology. Recurrent topics in Marc K. Hellerstein's work include Diet and metabolism studies (53 papers), Liver Disease Diagnosis and Treatment (47 papers) and Adipose Tissue and Metabolism (46 papers). Marc K. Hellerstein is often cited by papers focused on Diet and metabolism studies (53 papers), Liver Disease Diagnosis and Treatment (47 papers) and Adipose Tissue and Metabolism (46 papers). Marc K. Hellerstein collaborates with scholars based in United States, United Kingdom and Canada. Marc K. Hellerstein's co-authors include Richard A. Neese, Elizabeth J. Parks, Scott Turner, Denise Cesar, Joseph M. McCune, Krista A Varady, Mads Christiansen, Rebecca Hoh, Mark Fitch and Mark P. Christiansen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Marc K. Hellerstein

290 papers receiving 18.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

2015 810 citations Mark Fitch, Marc K. Hellerstein et al. profile →
Cholesterol Efflux and Atheroprotection

2012 740 citations Marc K. Hellerstein et al. profile →
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

2019 534 citations Gordon I. Smith, Mahalakshmi Shankaran et al. Journal of Clinical Investigation profile →
Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

2001 519 citations Steven G. Deeks, Teri Liegler et al. profile →
SIRT5 Regulates both Cytosolic and Mitochondrial Protein Malonylation with Glycolysis as a Major Target

2015 358 citations Mark Fitch, Marc K. Hellerstein et al. profile →
Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity

2024 50 citations Gordon I. Smith, Hector H. Palacios et al. profile →

Peers

Countries citing papers authored by Marc K. Hellerstein

Since Specialization

Citations

This map shows the geographic impact of Marc K. Hellerstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc K. Hellerstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc K. Hellerstein more than expected).

Fields of papers citing papers by Marc K. Hellerstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc K. Hellerstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc K. Hellerstein. The network helps show where Marc K. Hellerstein may publish in the future.

Co-authorship network of co-authors of Marc K. Hellerstein

This figure shows the co-authorship network connecting the top 25 collaborators of Marc K. Hellerstein. A scholar is included among the top collaborators of Marc K. Hellerstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc K. Hellerstein. Marc K. Hellerstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of inhibition of Janus kinase signalling during controlled mechanical ventilation on the rate of skeletal muscle protein synthesis 2025 ·The Journal of Physiology ·William J. Evans, Mahalakshmi Shankaran, Lars Larsson, Nicola Cacciani, Yvette Hedström, James L. Kirkland, Tamar Tchkonia, (unknown), Tyler Field, Marc K. Hellerstein	0
2	FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma 2024 ·Molecular Cancer Research ·(unknown), (unknown), Peter‐James H. Zushin, (unknown), Hyo Min Park, (unknown), (unknown), (unknown), Sharon M. Louie, (unknown), Marc K. Hellerstein, Daniel K. Nomura, (unknown), (unknown), Diego F. Calvisi, Xin Chen, Andreas Stahl	3
3	Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years 2024 ·The Journal of Physiology ·William J. Evans, Marc K. Hellerstein, Russell J. Butterfield, Edward C. Smith, Michela Guglieri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. James, Tyler Field, (unknown), Mahalakshmi Shankaran	4
4	Adipocyte lipin 1 expression associates with human metabolic health and regulates systemic metabolism in mice 2024 ·Journal of Clinical Investigation ·(unknown), Jason Singer, Daniel Ferguson, Trevor M. Shew, (unknown), Hector H. Palacios, Rachael L. Field, (unknown), (unknown), Mahalakshmi Shankaran, Gordon I. Smith, Jun Yoshino, Mai He, Gary J. Patti, Marc K. Hellerstein, Samuel Klein, Jonathan R. Brestoff, E. Matthew Morris, Brian N. Finck, (unknown)	0
5	Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence 2023 ·Nature Communications ·Daniel B. Reeves, (unknown), Mark Fitch, Mohamed Abdel‐Mohsen, Rebecca Hoh, Haelee Ahn, Mars Stone, Frederick Hecht, Jeffrey N. Martin, Steven G. Deeks, Marc K. Hellerstein, Joseph M. McCune, Joshua T. Schiffer, Peter W. Hunt	13
6	Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer 2023 ·Cancer Epidemiology Biomarkers & Prevention ·En Cheng, Bette J. Caan, Peggy M. Cawthon, William J. Evans, Marc K. Hellerstein, Mahalakshmi Shankaran, Edna Nyangau, Kristin L. Campbell, Catherine Lee, Alexandra M. Binder, Jeffrey A. Meyerhardt, Kathryn H. Schmitz, Elizabeth M. Cespedes Feliciano	5
7	Aging alters the metabolic flux signature of the ER‐unfolded protein response in vivo in mice 2022 ·Aging Cell ·(unknown), (unknown), Samuel Yuen, (unknown), Hector H. Palacios, Edna Nyangau, (unknown), (unknown), (unknown), (unknown), Holly K. Gildea, Andrew Dillin, Marc K. Hellerstein	10
8	HIV-1 Genomes Are Enriched in Memory CD4 ⁺ T-Cells with Short Half-Lives 2021 ·mBio ·(unknown), (unknown), (unknown), Bethany A. Horsburgh, Bonnie Hiener, (unknown), Timothy E. Schlub, Mark Fitch, Rebecca Hoh, Frederick Hecht, Jeffrey N. Martin, Steven G. Deeks, Marc K. Hellerstein, Joseph M. McCune, Peter W. Hunt, Sarah Palmer	17
9	Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease 2021 ·Journal of Clinical Investigation ·(unknown), Kelvin W. Li, Adina Alazraki, Carine Beysen, (unknown), Rebecca Cleeton, (unknown), Janet Figueroa, Jack Knight‐Scott, Cynthia Knott, Kimberly P. Newton, Edna Nyangau, Claude B. Sirlin, Patricia Ugalde‐Nicalo, Jean A. Welsh, Marc K. Hellerstein, Jeffrey B. Schwimmer, Miriam B. Vos	51
10	What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? 2020 ·Vaccine X ·Marc K. Hellerstein	52
11	CD57+ Memory T Cells Proliferate In Vivo 2020 ·Cell Reports ·Raya Ahmed, Kelly L. Miners, (unknown), Rhiannon E. Jones, Lauréline Roger, C. Baboonian, Yan Zhang, Eddie C. Y. Wang, Marc K. Hellerstein, Joseph M. McCune, Duncan M. Baird, David A. Price, Derek C. Macallan, Becca Asquith, Kristin Ladell	27
12	Adipose depot-specific effects of 16 weeks of pioglitazone on in vivo adipogenesis in women with obesity: a randomised controlled trial 2020 ·Diabetologia ·Ursula White, Mark Fitch, Robbie A. Beyl, Marc K. Hellerstein, Éric Ravussin	28
13	A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals 2017 ·SHILAP Revista de lepidopterología ·Leslie R. Cockerham, Steven A. Yukl, (unknown), Ma Somsouk, Sunil K. Joshi, Elizabeth Sinclair, Teri Liegler, Rebecca Hoh, (unknown), Peter W. Hunt, Adam Rupert, Irini Sereti, David R. Morcock, Ajantha Rhodes, Claire Emson, Marc K. Hellerstein, Jacob D. Estes, Sharon R. Lewin, Steven G. Deeks, Hiroyu Hatano	9
14	Comparison of muscle/lean mass measurement methods: correlation with functional and biochemical testing 2017 ·Osteoporosis International ·Bjoern Buehring, (unknown), Diane Krueger, William J. Evans, Marc K. Hellerstein, Yosuke Yamada, Neil Binkley	42
15	Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice 2015 ·Aging Cell ·(unknown), Matthew D. Bruss, John C. Price, Cyrus F. Khambatta, William E. Holmes, (unknown), (unknown), Lindsay S. Roberts, Clinton M. Astle, (unknown), Marc K. Hellerstein	25
16	Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells 2011 ·Molecular Medicine ·Carlo Calissano, Rajendra N. Damle, Sonia Marsilio, Xiao‐Jie Yan, Sophia Yancopoulos, Gregory M. Hayes, Claire Emson, Elizabeth J. Murphy, Marc K. Hellerstein, Cristina Sison, Matthew Kaufman, Jonathan E. Kolitz, Steven L. Allen, R. Kanti, (unknown), Igor Dozmorov, Sergio Roa, Matthew D. Scharff, Wentian Li, Nicholas Chiorazzi	129
17	Antimitotic Peptide Characterized from Soybean: Role in Protection from Cancer? 2009 ·Nutrition Reviews ·Marc K. Hellerstein	2
18	Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis 2008 ·Cancer Research ·Jeewon Kim, Yoon‐La Choi, Alice Vallentin, (unknown), Marc K. Hellerstein, Donna M. Peehl, Daria Mochly‐Rosen	44
19	Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection 2003 ·Journal of Clinical Investigation ·Marc K. Hellerstein, Rebecca Hoh, Mary Beth Hanley, Denise Cesar, Daniel Lee, Richard A. Neese, Joseph M. McCune	163
20	Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100 2000 ·Journal of Clinical Investigation ·Murielle M. Véniant, (unknown), Sun K. Kim, Patricia Ambroziak, Alice Chu, Martha D. Wilson, Marc K. Hellerstein, Lawrence L. Rudel, Rosemary L. Walzem, Stephen G. Young	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact